<?xml version="1.0" encoding="UTF-8"?>
<p>Once a CHIKV-infected vector bites a human host and transmits the virus, an asymptomatic incubation period begins, ranging from one to twelve days with an average of two to four days [
 <xref rid="pone.0174293.ref001" ref-type="bibr">1</xref>, 
 <xref rid="pone.0174293.ref011" ref-type="bibr">11</xref>]. Following this incubation period, 15% of infections remain asymptomatic [
 <xref rid="pone.0174293.ref001" ref-type="bibr">1</xref>, 
 <xref rid="pone.0174293.ref003" ref-type="bibr">3</xref>], while others experience symptoms corresponding to the acute stage of infection, often including fever (temperatures above 39Â°C), arthralgia in small and large joints, and body rash, while vomiting and nausea are also common [
 <xref rid="pone.0174293.ref003" ref-type="bibr">3</xref>, 
 <xref rid="pone.0174293.ref011" ref-type="bibr">11</xref>, 
 <xref rid="pone.0174293.ref017" ref-type="bibr">17</xref>]. Acute symptoms generally last seven to ten days, but associated aches and pains can be long-lasting in 30% of patients marking the chronic stage of the infection [
 <xref rid="pone.0174293.ref017" ref-type="bibr">17</xref>]. Continuing long-term inflammation of the joints and connective tissue during the chronic stage may have disabling consequences similar to rheumatoid arthritis [
 <xref rid="pone.0174293.ref003" ref-type="bibr">3</xref>, 
 <xref rid="pone.0174293.ref011" ref-type="bibr">11</xref>]. Chikungunya is rarely fatal, but deaths can occur in the young, elderly, or those immunosuppressed or immunocompromised [
 <xref rid="pone.0174293.ref003" ref-type="bibr">3</xref>, 
 <xref rid="pone.0174293.ref011" ref-type="bibr">11</xref>, 
 <xref rid="pone.0174293.ref017" ref-type="bibr">17</xref>].
</p>
